Skip to main content
Top
Published in: Techniques in Coloproctology 3/2014

01-03-2014 | Original Article

Safety and factors contributing to the difficulty of laparoscopic surgery for rectal cancer treated with preoperative chemoradiotherapy

Authors: S. Ishihara, T. Watanabe, Y. Fukushima, T. Akahane, A. Horiuchi, R. Shimada, K. Nakamura, T. Hayama, H. Yamada, K. Nozawa, K. Matsuda, Y. Hashiguchi

Published in: Techniques in Coloproctology | Issue 3/2014

Login to get access

Abstract

Background

The safety of laparoscopic surgery for rectal cancer following chemoradiotherapy (CRT) has not been fully established. The aim of our retrospective study was to examine the outcomes and the factors contributing to the difficulty of laparoscopic surgery after CRT.

Methods

Eighty-seven consecutive rectal cancer patients treated with CRT were analyzed. Clinicopathological factors were compared between laparoscopic surgery (n = 57) and open surgery (n = 30) groups, and factors that correlated with operation time and blood loss were analyzed in low anterior resection (LAR) cases in the laparoscopic surgery group (n = 46).

Results

There was less blood loss in the laparoscopic surgery group than in the open surgery group (191 vs. 1,043 ml, p = 0.0001), and the operation time in the two groups was similar (329 vs. 322 min, p = 0.8). The rate of conversion from laparoscopic surgery to open surgery was 1.8 %. There was no significant difference in the morbidity rate (laparoscopic surgery 22.8 % vs. open surgery 33.3 %, p = 0.3). All circumferential resection margins were clear. Three-year cumulative rates of local recurrence were as follows: laparoscopic surgery: 1.9 % vs. open surgery: 8.4 % (p = 0.4), and distant recurrence was 28.5 % in laparoscopic surgery vs. 22.7 % in open surgery (p = 0.8) and these rates were not significantly different. In laparoscopic LAR cases, a shorter distance of the tumor from the anal verge was associated with a longer operation time. A high computed tomography Hounsfield units value of the mesorectum (CTV) was associated with increased blood loss in the first 23 cases, but not in the other 23 cases.

Conclusions

Laparoscopic surgery following CRT was safe and feasible. A shorter anal verge was associated with a longer operation time. Blood loss increased in cases with high CTV, but this can likely be mitigated by experience.
Literature
1.
go back to reference Clinical outcomes of surgical therapy study group (2004) A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 350:2050–2059 Clinical outcomes of surgical therapy study group (2004) A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 350:2050–2059
2.
go back to reference Jayne DG, Guillou PJ, Thorpe H et al (2007) Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 25:3061–3068PubMedCrossRef Jayne DG, Guillou PJ, Thorpe H et al (2007) Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 25:3061–3068PubMedCrossRef
3.
go back to reference Lacy AM, Delgado S, Castells A et al (2008) The long-term results of a randomized clinical trial of laparoscopy-assisted versus open surgery for colon cancer. Ann Surg 248:1–7PubMedCrossRef Lacy AM, Delgado S, Castells A et al (2008) The long-term results of a randomized clinical trial of laparoscopy-assisted versus open surgery for colon cancer. Ann Surg 248:1–7PubMedCrossRef
4.
go back to reference Buunen M, Veldkamp R, Hop WC et al (2009) Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol 10:44–52PubMedCrossRef Buunen M, Veldkamp R, Hop WC et al (2009) Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol 10:44–52PubMedCrossRef
5.
go back to reference Ceelen WP (2007) Use of laparoscopy for rectal cancer: a word of caution. J Clin Oncol 25:5040; author reply 5040–5041 Ceelen WP (2007) Use of laparoscopy for rectal cancer: a word of caution. J Clin Oncol 25:5040; author reply 5040–5041
6.
go back to reference Guillou PJ, Quirke P, Thorpe H et al (2005) Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 365:1718–1726PubMedCrossRef Guillou PJ, Quirke P, Thorpe H et al (2005) Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 365:1718–1726PubMedCrossRef
7.
go back to reference Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U (2005) Swedish rectal cancer trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 23:5644–5650PubMedCrossRef Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U (2005) Swedish rectal cancer trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 23:5644–5650PubMedCrossRef
8.
go back to reference Peeters KC, Marijnen CA, Nagtegaal ID et al (2007) The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246:693–701PubMedCrossRef Peeters KC, Marijnen CA, Nagtegaal ID et al (2007) The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246:693–701PubMedCrossRef
9.
go back to reference Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740PubMedCrossRef Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740PubMedCrossRef
10.
go back to reference Ishihara S, Hayama T, Yamada H, Nozawa K, Matsuda K, Watanabe T (2011) Benefit of tegafur-uracil and leucovorin in chemoradiotherapy for rectal cancer. Hepatogastroenterology 58:756–762PubMed Ishihara S, Hayama T, Yamada H, Nozawa K, Matsuda K, Watanabe T (2011) Benefit of tegafur-uracil and leucovorin in chemoradiotherapy for rectal cancer. Hepatogastroenterology 58:756–762PubMed
11.
go back to reference Ishihara S, Watanabe T, Akahane T et al (2011) Prognostic significance of adverse events associated with preoperative radiotherapy for rectal cancer. Int J Colorectal Dis 26:911–917PubMedCrossRef Ishihara S, Watanabe T, Akahane T et al (2011) Prognostic significance of adverse events associated with preoperative radiotherapy for rectal cancer. Int J Colorectal Dis 26:911–917PubMedCrossRef
12.
go back to reference Ishihara S, Watanabe T, Nagawa H (2008) Intraoperative colonoscopy for stapled anastomosis in colorectal surgery. Surg Today 38:1063–1065PubMedCrossRef Ishihara S, Watanabe T, Nagawa H (2008) Intraoperative colonoscopy for stapled anastomosis in colorectal surgery. Surg Today 38:1063–1065PubMedCrossRef
13.
go back to reference Akiyoshi T, Kuroyanagi H, Oya M, Konishi T et al (2009) Factors affecting the difficulty of laparoscopic total mesorectal excision with double stapling technique anastomosis for low rectal cancer. Surgery 146:483–489PubMedCrossRef Akiyoshi T, Kuroyanagi H, Oya M, Konishi T et al (2009) Factors affecting the difficulty of laparoscopic total mesorectal excision with double stapling technique anastomosis for low rectal cancer. Surgery 146:483–489PubMedCrossRef
14.
go back to reference Mindelzun RE, Jeffrey RB Jr, Lane MJ, Silverman PM (1996) The misty mesentery on CT: differential diagnosis. AJR Am J Roentgenol 167:61–65PubMedCrossRef Mindelzun RE, Jeffrey RB Jr, Lane MJ, Silverman PM (1996) The misty mesentery on CT: differential diagnosis. AJR Am J Roentgenol 167:61–65PubMedCrossRef
15.
go back to reference Kuroyanagi H, Oya M, Ueno M, Fujimoto Y, Yamaguchi T, Muto T (2008) Standardized technique of laparoscopic intracorporeal rectal transection and anastomosis for low anterior resection. Surg Endosc 22:557–561PubMedCrossRef Kuroyanagi H, Oya M, Ueno M, Fujimoto Y, Yamaguchi T, Muto T (2008) Standardized technique of laparoscopic intracorporeal rectal transection and anastomosis for low anterior resection. Surg Endosc 22:557–561PubMedCrossRef
16.
go back to reference Denoya P, Wang H, Sands D, Nogueras J, Weiss E, Wexner SD (2010) Short-term outcomes of laparoscopic total mesorectal excision following neoadjuvant chemoradiotherapy. Surg Endosc 24:933–938PubMedCrossRef Denoya P, Wang H, Sands D, Nogueras J, Weiss E, Wexner SD (2010) Short-term outcomes of laparoscopic total mesorectal excision following neoadjuvant chemoradiotherapy. Surg Endosc 24:933–938PubMedCrossRef
17.
go back to reference Denost Q, Laurent C, Paumet T, Quintane L, Martenot M, Rullier E (2012) Laparoscopic surgery for rectal cancer: preoperative radiochemotherapy versus surgery alone. Surg Endosc 26:1878–1883PubMedCrossRef Denost Q, Laurent C, Paumet T, Quintane L, Martenot M, Rullier E (2012) Laparoscopic surgery for rectal cancer: preoperative radiochemotherapy versus surgery alone. Surg Endosc 26:1878–1883PubMedCrossRef
18.
go back to reference Rosati R, Bona S, Romario UF, Elmore U, Furlan N (2007) Laparoscopic total mesorectal excision after neoadjuvant chemoradiotherapy. Surg Oncol 16(Suppl 1):S83–S89PubMedCrossRef Rosati R, Bona S, Romario UF, Elmore U, Furlan N (2007) Laparoscopic total mesorectal excision after neoadjuvant chemoradiotherapy. Surg Oncol 16(Suppl 1):S83–S89PubMedCrossRef
19.
go back to reference Akiyoshi T, Kuroyanagi H, Oya M et al (2009) Safety of laparoscopic total mesorectal excision for low rectal cancer with preoperative chemoradiation therapy. J Gastrointest Surg 13:521–525PubMedCrossRef Akiyoshi T, Kuroyanagi H, Oya M et al (2009) Safety of laparoscopic total mesorectal excision for low rectal cancer with preoperative chemoradiation therapy. J Gastrointest Surg 13:521–525PubMedCrossRef
20.
go back to reference Kang SB, Park JW, Jeong SY et al (2010) Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol 11:637–645PubMedCrossRef Kang SB, Park JW, Jeong SY et al (2010) Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol 11:637–645PubMedCrossRef
21.
go back to reference Cone MM, Lu KC, Herzig DO, Rea JD, Diggs BS, Oommen SC (2011) Laparoscopic proctectomy after neoadjuvant therapy: safety and long-term follow-up. Surg Endosc 25:1902–1906PubMedCrossRef Cone MM, Lu KC, Herzig DO, Rea JD, Diggs BS, Oommen SC (2011) Laparoscopic proctectomy after neoadjuvant therapy: safety and long-term follow-up. Surg Endosc 25:1902–1906PubMedCrossRef
22.
go back to reference Motson RW, Khan JS, Arulampalam TH, Austin RC, Lacey N, Sizer B (2011) Laparoscopic total mesorectal excision following long course chemoradiotherapy for locally advanced rectal cancer. Surg Endosc 25:1753–1760PubMedCrossRef Motson RW, Khan JS, Arulampalam TH, Austin RC, Lacey N, Sizer B (2011) Laparoscopic total mesorectal excision following long course chemoradiotherapy for locally advanced rectal cancer. Surg Endosc 25:1753–1760PubMedCrossRef
23.
go back to reference Ishihara S, Iinuma H, Fukushima Y et al (2012) Radiation-induced apoptosis of peripheral blood lymphocytes is correlated with histological regression of rectal cancer in response to preoperative chemoradiotherapy. Ann Surg Oncol 19:1192–1198PubMedCrossRef Ishihara S, Iinuma H, Fukushima Y et al (2012) Radiation-induced apoptosis of peripheral blood lymphocytes is correlated with histological regression of rectal cancer in response to preoperative chemoradiotherapy. Ann Surg Oncol 19:1192–1198PubMedCrossRef
24.
go back to reference Rodel C, Liersch T, Becker H et al (2012) Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol 13:679–687PubMedCrossRef Rodel C, Liersch T, Becker H et al (2012) Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol 13:679–687PubMedCrossRef
25.
go back to reference Sato T, Ozawa H, Hatate K et al (2011) A Phase II trial of neoadjuvant preoperative chemoradiotherapy with S-1 plus irinotecan and radiation in patients with locally advanced rectal cancer: clinical feasibility and response rate. Int J Radiat Oncol Biol Phys 79:677–683PubMedCrossRef Sato T, Ozawa H, Hatate K et al (2011) A Phase II trial of neoadjuvant preoperative chemoradiotherapy with S-1 plus irinotecan and radiation in patients with locally advanced rectal cancer: clinical feasibility and response rate. Int J Radiat Oncol Biol Phys 79:677–683PubMedCrossRef
Metadata
Title
Safety and factors contributing to the difficulty of laparoscopic surgery for rectal cancer treated with preoperative chemoradiotherapy
Authors
S. Ishihara
T. Watanabe
Y. Fukushima
T. Akahane
A. Horiuchi
R. Shimada
K. Nakamura
T. Hayama
H. Yamada
K. Nozawa
K. Matsuda
Y. Hashiguchi
Publication date
01-03-2014
Publisher
Springer Milan
Published in
Techniques in Coloproctology / Issue 3/2014
Print ISSN: 1123-6337
Electronic ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-013-1048-1

Other articles of this Issue 3/2014

Techniques in Coloproctology 3/2014 Go to the issue